Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)
Clinical trial NCT07109414 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07109414
- Sponsor
- Novita Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-29
- Primary completion
- 2028-10-25
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.